Kynurenine pathway metabolism in the galactosamine model of hepatic injury.
Saito
K
K
Department of Laboratory Medicine, Gifu University School of Medicine, Japan.
Seishima
M
M
Noma
A
A
Nagamura
Y
Y
Quearry
B J
BJ
Markey
S P
SP
Heyes
M P
MP
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005688:Galactosamine / Q000633:toxicity*; D005849:Gerbillinae; D006501:Hepatic Encephalopathy / Q000378:metabolism*; D007737:Kynurenine / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D017378:Quinolinic Acid / Q000378:metabolism*; D012475:Salmonella; D014366:Tryptophan Oxygenase / Q000378:metabolism
D008070:Lipopolysaccharides; D007737:Kynurenine; D005688:Galactosamine; D014366:Tryptophan Oxygenase; D017378:Quinolinic Acid